Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenProbio is a leading Chinese biotechnology company specializing in the research, development, and industrialization of probiotic strains and lactic acid bacteria. The company maintains one of the world's largest lactic acid bacteria strain libraries, originating from extensive research at Inner Mongolia Agricultural University. GenProbio provides high-quality probiotic ingredients and finished products for the food, healthcare, and pharmaceutical industries. Their scientific focus centers on the gut microbiome's role in human health, specifically targeting digestive health, immunity, and metabolic regulation. The company is recognized for its rigorous clinical validation of proprietary strains such as Lactobacillus casei Zhang.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GenProbio.